Early markers of cognitive enhancement: Developing an implicit measure of cognitive performance

Psychopharmacology

Volumn 230, Issue 4, 2013, Pages 631-638

  Pringle, Abbie ^a,c   Browning, Michael ^b   Parsons, Elizabeth ^a   Cowen, Phil J ^a   Harmer, Catherine J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Cognitive enhancement; Modafinil; Set shifting

Indexed keywords

MODAFINIL; PLACEBO;

ACCURACY; ADULT; ALERTNESS; ARTICLE; ATTENTION; BECK DEPRESSION INVENTORY; BEFINDLICHKEITS SCALE; COGNITION; FEMALE; HUMAN; HUMAN EXPERIMENT; LEARNING; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NORMAL HUMAN; POSITIVE AND NEGATIVE AFFECT SCHEDULE; PRIORITY JOURNAL; RESPONSE TIME; SINGLE DRUG DOSE; STATE TRAIT ANXIETY INVENTORY; TASK PERFORMANCE; VISUAL ANALOG SCALE; VOLUNTEER; YOUNG ADULT;

ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEARNING; MALE; MIDDLE AGED; NOOTROPIC AGENTS; REACTION TIME; TASK PERFORMANCE AND ANALYSIS; WAKEFULNESS-PROMOTING AGENTS; YOUNG ADULT;

EID: 84890431177     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3186-6     Document Type: Article

References (37)

1. Baranski JV, Pigeau R, Dinich P, Jacobs I (2004) Effects of modafinil on cognitive and meta-cognitive performance. Human Psychopharmacology 19:323-332
2. Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD (2010) Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev 34:1161-1177
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
4. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
5. Cleeremans A (2006) Conscious and unconscious cognition: a graded dynamic perspective. Psychology Press, Hove
6. Eysenck SBG, Eysenck HJ, Barrett P (1985) A revised version of the psychoticism scale. Personal Individ Differ 6:21-29
7. First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for axis I and II DSM-IV disorders: patient edition (SCID-IV/P). Biometrics Research Department, New York
8. Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, Lopez-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW (2009) Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res 115:104-114
9. Harmer C, Cowen P, Goodwin G (2011) Efficacy markers in depression. J Psychopharmacol (Oxford, England) 25:1148-1158
10. Hunter MD, Ganesan V, Wilkinson ID, Spence SA (2006) Impact of modafinil on prefrontal executive function in schizophrenia. Am J Psychiatry 163:2184-2186
11. Husain M, Mehta MA (2011) Cognitive enhancement by drugs in health and disease. Trends Cogn Sci 15:28-36
12. Kaufman SB, Deyoung CG, Gray JR, Jimenez L, Brown J, Mackintosh N (2010) Implicit learning as an ability. Cognition 116:321-340
13. Loose R, Kaufmann C, Tucha O, Auer DP, Lange KW (2006) Neural networks of response shifting: influence of task speed and stimulus material. Brain Res 1090:146-155
14. MacLeod CM, Mathews A, Tata P (1986) Attentional bias in emotional disorders. J Abnorm Psychol 95:15-20
15. Marchant NL, Kamel F, Echlin K, Grice J, Lewis M, Rusted JM (2009) Modafinil improves rapid shifts of attention. Psychopharmacology (Berl) 202:487-495
16. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:RC65
17. Millan MJ, Agid Y, Brune M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, Joels M, Mansuy IM, Meyer-Lindenberg A, Murphy D, Rolls E, Saletu B, Spedding M, Sweeney J, Whittington M, Young LJ (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11:141-168
18. Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33:1477-1502
19. Muller U, Rowe JB, Rittman T, Lewis C, Robbins TW, Sahakian BJ (2013) Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64:490-495
20. Murphy SE, Longhitano CL, Ayres RE, Cowen PJ, Harmer CJ (2006) Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology 187:121-130
21. Nelson HE (1982) National Adult Reading Test (NART): test manual. NFER-Nelson, Windsor
22. Nosek BA, Hawkins CB, Frazier RS (2011) Implicit social cognition: from measures to mechanisms. Trends Cogn Sci 15:152-159
23. Randall DC, Shneerson JM, Plaha KK, File SE (2003) Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 18:163-173
24. Randall DC, Fleck NL, Shneerson JM, File SE (2004) The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav 77:547-555
25. Randall DC, Shneerson JM, File SE (2005a) Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav 82:133-139
26. Randall DC, Viswanath A, Bharania P, Elsabagh SM, Hartley DE, Shneerson JM, File SE (2005b) Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol 25:175-179
27. Rasetti R, Mattay VS, Stankevich B, Skjei K, Blasi G, Sambataro F, Arrillaga-Romany IC, Goldberg TE, Callicot JH, Apud JA, Weinberger DR (2010) Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology 35:2101-2109
28. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267-287
29. Spielberger CD, Gorsuch RL, Lushene RD (1970) STAI manual. Consulting Psychologists Press, Palo Alto
30. Stacy AW, Wiers RW (2010) Implicit cognition and addiction: a tool for explaining paradoxical behavior. Annu Rev Clin Psychol 6:551-575
31. Sylvester CY, Wager TD, Lacey SC, Hernandez L, Nichols TE, Smith EE, Jonides J (2003) Switching attention and resolving interference: fMRI measures of executive functions. Neuropsychologia 41:357-370
32. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165:260-269
33. Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ (2004a) Modafinil improves cognition and response inhibition in adult attention-deficit/ hyperactivity disorder. Biol Psychiatry 55:1031-1040
34. Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (2004b) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29:1363-1373
35. von Zerseen D, Strian F, Schwarz D (1974) Evaluation of depressive states, especially in longitudinal studies. In: Pichot B (ed) Psychological measurements in psychopharmacology. Karger, Basel
36. Watson D, Clarke LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the positive and negative affect schedule scales. J Personal Soc Psychol 54:1063-1070
37. Wiers RW, Teachman BA, De Houwer J (2007) Implicit cognitive processes in psychopathology: an introduction. J Behav Ther Exp Psychiatry 38:95-104